FindTrial
Sign In

Ultrasonographic guided intra-articular 5%bufferd dextrose with Perineural injection around the shoulder versus intra-articular steroid injection in frozen shoulder with and without suprascapular nerve block.

Ultrasonographic guided intra-articular 5%bufferd dextrose with Perineural injection around the shoulder versus intra-articular steroid injection in frozen shoulder with and without suprascapular nerve block.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202504907299468
Enrollment
100
Registered
2025-04-07
Start date
2023-08-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Diseases

Interventions

ultrasound guided intra articular injection of steroid in patients with with SSNB
local injection
ultrasound guided intra articular injection of buffered dextrose in patients with with SSNB
ultrasound guided intra articular injection of buffered dextrose in patients with without SSNB

Sponsors

rheumatology departement
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1-complete history taking. 2-complete examination of the shoulder. 3-frozen shoulder (insidious onset with a progressive increase in pain, and a gradual decrease in active and passive range of motion) 4-plain-x-ray to the shoulder . 5-MRI to the shoulder . 6-ESR,CRP,RF. D.M 7-age from 45 to 64 years.

Exclusion criteria

Exclusion criteria: 1-Secondary etiology of shoulder ache (e.g., acute trauma, fractures, bony deformities, and glenohumeral joint disease) 2-hemiplegia 3-cervical disc and spondylosis are contraindicated for block therapies (e.g., bleeding disorder and infection) and chronic medical diseases were excluded from this study.

Design outcomes

Primary

MeasureTime frame
evaluating the efficacy of dextrose injection versus dextrose injection by VAS score and pain score and disability score . There was no statistically significant difference between either studied groups regarding VAS at the 1st week. In contrast, there was a highly statistically significant difference between them regarding VAS at baseline, 3rd, 6th week. However, There was a highly statistically significant difference between both studied groups regarding pain score at baseline, 1st, 3rd, 6th week However, There was highly statistically significant difference between both studied groups regarding disability score at baseline, 1st, 3rd, 6th week—

Secondary

MeasureTime frame
to evaluate the efficacy of dextrose versus cortisone injection in and around the shoulder in the second to the six week—

Countries

Egypt

Contacts

Public Contactawwad saad

assistant professor of rheumatology departement

drawwad66@yahoo.com01020907414

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026